Pfizer, looking for a jumpstart, leans into cancer drug research
BioPharma Drive: Drug Pricing
MARCH 1, 2024
Reeling from a difficult year financially, the pharma unveiled a new oncology division it says will produce eight billion-dollar medicines by 2030.
Let's personalize your content